This book informs the reader of the essential information for Running a Safe, Successful Acupuncture Clinic. Split into three sections cover Techniques and Safety (Risk Management), Ethics and Interpersonal Skills and Clinic Management, these three areas provide vital knowledge to any acupuncturist, regardless of whether a new practitioner or one already in practice with several years experience. Standing as an easy-to-use reference book as well as a comprehensive textbook this book is an essential read. - an excellent valuable addition for everyone associated with acupuncture and traditional chinese medicine - offers everything you need to know in an acupuncture clinic - chapters cover essential areas such as safety, risk, ethics and interpersonal skills and clinic management - written by a leading practitioner in the field with a considerable understanding of the particular needs and unique aspects of running an acupuncture clinic - aimed to be accessible to both the new and experienced practitoners

Ear Acupuncture provides an up-to-date practical guide to the principles and practice of Chinese and Western ear acupuncture. Written clearly with a practical and sensible approach, this book is aimed at both the student and also the practitioner. Excellent two-colour illustrations are used throughout to illustrate the text. Additionally, it integrates the Chinese and Western opinions and also includes chapters covering ear acupuncture used in the treatment of addiction and also the Western theories about how acupuncture works. - Written with a practical and very sensible approach - Clearly presented and easy to read - Excellent 2-colour illustrations are used throughout to illustrate the text - Includes an appendix of acupuncture points

The new WHO guidelines provide recommended steps for safe phlebotomy and reiterate accepted principles for drawing, collecting blood and transporting blood to laboratories/blood banks. The main areas covered by the toolkit are: 1. bloodborne pathogens transmitted through unsafe injection practices;2. relevant elements of standard precautions and associated barrier protection;3. best injection and related infection prevention and control practices;4. occupational risk factors and their management.

The aim of this book is to reduce the risks of medical treatment and enhance the safety of patients in all areas of healthcare. The first section discusses human error, the incidence of harm to patients, and the development or risk management. Chapters in the second section discuss the reduction of risk in clinical practice in key medical specialties. The third section discusses features of the healthcare systems that are essential to safe practice, such as communication of risk to patients, the design of equipment, supervision and training, and effective teamwork. The fourth section describes how to put risk management into practice, including the effective and sensitive handling of complaints and claims, the care of injured patients and the staff involved, and the reporting, investigation and analysis of serious incidents.

Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.